Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
Globenewswire -
Nổi bật :
Shell plc publishes first quarter 2026 press release
Globenewswire -
Iveco Group 2026 First Quarter Results
Globenewswire -
Fortinet Reports Strong First Quarter 2026 Financial Results
Globenewswire -
Iveco Group Calls the Annual General Meeting
Globenewswire -
MỚI NHẤT
QUAN TÂM
